{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:44:48Z","timestamp":1788299088450,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102253","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T16:10:44Z","timestamp":1718467844000},"page":"102253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unbiased plasma profiling using pre-selected RNA aptamer pools predicts mortality in COVID-19 and identifies protein risk factors"],"prefix":"10.1016","volume":"35","author":[{"given":"Asger Givskov","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Miotto","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Fjelstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie Bo","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.H.","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102253_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12939-022-01629-0","article-title":"COVID-19 double jeopardy: the overwhelming impact of the social determinants of health","volume":"21","author":"Badalov","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"10.1016\/j.omtn.2024.102253_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/d41586-023-02656-9","article-title":"Why a highly mutated coronavirus variant has scientists on alert","volume":"620","author":"Callaway","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102253_bib3","author":"Institut"},{"key":"10.1016\/j.omtn.2024.102253_bib4","author":"Organisation"},{"key":"10.1016\/j.omtn.2024.102253_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik","year":"2021","journal-title":"BMJ Evid. Based. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtn.2024.102253_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2024.102253_bib9","doi-asserted-by":"crossref","first-page":"103276","DOI":"10.1016\/j.ipm.2023.103276","article-title":"Gender and sex bias in COVID-19 epidemiological data through the lens of causality","volume":"60","author":"D\u00edaz-Rodr\u00edguez","year":"2023","journal-title":"Inf. Process. Manag."},{"key":"10.1016\/j.omtn.2024.102253_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib11","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102253_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jcmm.17622","article-title":"COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management","volume":"27","author":"Iosef","year":"2023","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omtn.2024.102253_bib14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib15","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.omtn.2024.102253_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and Metabolomic Characterization of COVID-19 Patient Sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102253_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-020-01633-7","article-title":"Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study","volume":"18","author":"Shi","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.omtn.2024.102253_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000521612","article-title":"Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3","volume":"14","author":"Hansen","year":"2022","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.omtn.2024.102253_bib19","doi-asserted-by":"crossref","first-page":"zcac025","DOI":"10.1093\/narcan\/zcac025","article-title":"Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer","volume":"4","author":"Fjelstrup","year":"2022","journal-title":"NAR Cancer"},{"key":"10.1016\/j.omtn.2024.102253_bib20","first-page":"e139","article-title":"Characterisation of aptamer\u2013target interactions by branched selection and high-throughput sequencing of SELEX pools","volume":"43","author":"Dupont","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102253_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender Differences in Patients With COVID-19: Focus on Severity and Mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front. Public Health"},{"key":"10.1016\/j.omtn.2024.102253_bib22","unstructured":"Uniprot Proteomes \u00b7 Homo Sapiens (Human); https:\/\/www.uniprot.org\/uniprotkb?query=UP000005640"},{"key":"10.1016\/j.omtn.2024.102253_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma Proteome Profiling to Assess Human Health and Disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst."},{"key":"10.1016\/j.omtn.2024.102253_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88679-6","article-title":"The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients","volume":"11","author":"Antunez Mui\u00f1os","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102253_bib26","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1038\/s41598-021-81844-x","article-title":"Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients","volume":"11","author":"Jimenez-Solem","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102253_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.2021.279155","article-title":"Complement dysregulation is associated with severe COVID-19 illness","volume":"107","author":"Yu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.omtn.2024.102253_bib28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102253_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The Factor H protein family: The switchers of the complement alternative pathway","volume":"313","author":"Lucientes-Continente","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtn.2024.102253_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102253_bib31","doi-asserted-by":"crossref","first-page":"1032331","DOI":"10.3389\/fimmu.2022.1032331","article-title":"Levels of soluble complement regulators predict severity of COVID-19 symptoms","volume":"13","author":"Tierney","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102253_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/jiac091","article-title":"Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019","volume":"226","author":"Castanha","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102253_bib33","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1021\/acsomega.1c00616","article-title":"Proteomics Analysis of Serum from COVID-19 Patients","volume":"6","author":"Liu","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.omtn.2024.102253_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26508\/lsa.202101099","article-title":"A serum proteome signature to predict mortality in severe covid-19 patients","volume":"4","author":"V\u00f6llmy","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.omtn.2024.102253_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2006.0059","article-title":"Simultaneous Generation of Aptamers to Multiple Gamma-Carboxyglutamic Acid Proteins from a Focused Aptamer Library Using DeSELEX and Convergent Selection","volume":"17","author":"Layzer","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.omtn.2024.102253_bib36","doi-asserted-by":"crossref","first-page":"34193","DOI":"10.1074\/jbc.M504772200","article-title":"Deconvolution of a Complex Target Using DNA Aptamers","volume":"280","author":"Fitter","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102253_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/wrna.1360","article-title":"Expected and unexpected features of protein-binding RNA aptamers","volume":"7","author":"Bjerregaard","year":"2016","journal-title":"WIREs RNA"},{"key":"10.1016\/j.omtn.2024.102253_bib38","first-page":"a05200313","article-title":"Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020","volume":"67","author":"Israelsen","year":"2020","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.omtn.2024.102253_bib39","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/cid\/ciab536","article-title":"Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study","volume":"73","author":"Benfield","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102253_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.32614\/RJ-2014-011","article-title":"The stringdist package for approximate string matching","volume":"6","year":"2014","journal-title":"R J."},{"key":"10.1016\/j.omtn.2024.102253_bib41","series-title":"ggpubr: \u201cggplot2\u201d Based Publication Ready Plots","author":"Kassambara","year":"2023"},{"key":"10.1016\/j.omtn.2024.102253_bib42","series-title":"pheatmap: Pretty Heatmaps","author":"Kolde","year":"2019"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T17:23:21Z","timestamp":1728321801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001409"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102253","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unbiased plasma profiling using pre-selected RNA aptamer pools predicts mortality in COVID-19 and identifies protein risk factors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102253"}}